Medial prefrontal cortex Transient Receptor Potential Vanilloid Type 1 (TRPV1) in the expression of contextual fear conditioning in Wistar rats

被引:33
|
作者
Terzian, Ana Luisa B. [1 ,2 ]
dos Reis, Daniel Gustavo [3 ]
Guimares, Francisco S. [3 ,4 ]
Correa, Fernando M. A. [3 ]
Resstel, Leonardo B. M. [3 ,4 ]
机构
[1] Max Planck Inst Psychiat, D-80804 Munich, Germany
[2] Univ Munich, Grad Sch Syst Neurosci, Munich, Germany
[3] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, BR-14049900 Sao Paulo, Brazil
[4] Univ Sao Paulo, Ctr Interdisciplinary Res Appl Neurosci NAPNA, BR-14049900 Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
Contextual fear; TRPV1; receptors; Prefrontal cortex; Cardiovascular system; Rats; CARDIOVASCULAR-RESPONSES; REVERSIBLE INACTIVATION; ENDOCANNABINOID SYSTEM; SYNAPTIC-TRANSMISSION; EMOTIONAL RESPONSES; INFRALIMBIC CORTEX; PRELIMBIC CORTEX; ANXIETY; MODULATION; LESIONS;
D O I
10.1007/s00213-013-3211-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Contextual fear is evoked by re-exposing an animal to an environment that has been previously paired with an aversive or unpleasant stimulus. It can be assessed by freezing and cardiovascular changes such as increase in mean arterial pressure and heart rate. A marked increase in neuronal activity is associated with contextual fear conditioning, especially in limbic structures involved with defense reactions, such as the ventral portion of medial prefrontal cortex. Given the fact that transient receptor potential vanilloid type 1 (TRPV1) receptors could be involved in the expression of defensive behavior, the present work tested the hypothesis that TRPV1 manipulation in the ventromedial prefrontal cortex (vMPFC) modulates the expression of contextual conditioned fear. Male Wistar rats received bilateral microinjections into the vMPFC of the TRPV1 receptor antagonists capsazepine (1, 10, and 60 nmol/200 nL) or 6-iodonordihydrocapsaicin (3 nmol/200 nL), and the TRPV1 agonist capsaicin (1 nmol/200 nL) preceded by vehicle or 6-iodonordihydrocapsaicin before re-exposure to the experimental chamber for 10 min, 48 h after conditioning in two different protocols distinct by their aversiveness. Both antagonists reduced the freezing and cardiovascular responses in the high aversive protocol. Capsaicin caused an increase in fear-associated responses that could be blocked by 6-iodonordihydrocapsaicin. Our results indicate that TRPV1 receptors located in the vMPFC have a tonic involvement in the modulation of the expression of contextual fear conditioning.
引用
收藏
页码:149 / 157
页数:9
相关论文
共 50 条
  • [31] CANNABINOID TYPE 1 RECEPTORS AND TRANSIENT RECEPTOR POTENTIAL VANILLOID TYPE 1 CHANNELS IN FEAR AND ANXIETY-TWO SIDES OF ONE COIN?
    Moreira, F. A.
    Aguiar, D. C.
    Terzian, A. L. B.
    Guimaraes, F. S.
    Wotjak, C. T.
    NEUROSCIENCE, 2012, 204 : 186 - 192
  • [32] Activation of the transient receptor potential vanilloid-1 (TRPV1) channel opens the gate for pain relief
    Jancso, G.
    Dux, M.
    Oszlacs, O.
    Santha, P.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 155 (08) : 1139 - 1141
  • [33] Upregulation of transient receptor potential ankyrin 1 (TRPA1) but not transient receptor potential vanilloid 1 (TRPV1) during primary tooth carious progression
    Wichaidit, Alisa
    Patinotham, Namthip
    Nukaeow, Kullanun
    Kaewpitak, Aunwaya
    JOURNAL OF ORAL BIOSCIENCES, 2023, 65 (01) : 24 - 30
  • [34] Transient receptor potential vanilloid 1 (TRPV1)-independent actions of capsaicin on cellular excitability and ion transport
    Oz, Murat
    Lorke, Dietrich E.
    Howarth, Frank C.
    MEDICINAL RESEARCH REVIEWS, 2023, 43 (04) : 1038 - 1067
  • [35] Riboflavin Inhibits Histamine-Dependent Itch by Modulating Transient Receptor Potential Vanilloid 1 (TRPV1)
    Lee, Kihwan
    Choi, Young In
    Im, Sang-Taek
    Hwang, Sung-Min
    Lee, Han-Kyu
    Im, Jay-Zoon
    Kim, Yong Ho
    Jung, Sung Jun
    Park, Chul-Kyu
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2021, 14
  • [36] Tetrahydropyridine-4-carboxamides as novel, potent transient receptor potential vanilloid 1 (TRPV1) antagonists
    Brown, Brian S.
    Keddy, Ryan
    Zheng, Guo Zhu
    Schmidt, Robert G.
    Koenig, John R.
    McDonald, Heath A.
    Bianchi, Bruce R.
    Honore, Prisca
    Jarvis, Michael F.
    Surowy, Carol S.
    Polakowski, James S.
    Marsh, Kennan C.
    Faltynek, Connie R.
    Lee, Chih-Hung
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (18) : 8516 - 8525
  • [37] 4-Aminophenyl acetamides and propanamides as potent transient receptor potential vanilloid 1 (TRPV1) ligands
    Kim, Changhoon
    Ann, Jihyae
    Lee, Sunho
    Kim, Eunhye
    Choi, Sun
    Blumberg, Peter M.
    Frank-Foltyn, Robert
    Bahrenberg, Gregor
    Stockhause, Hannelore
    Christoph, Thomas
    Lee, Jeewoo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (15) : 4509 - 4517
  • [38] Expression of transient receptor potential vanilloid-1 (TRPV1) in urothelial cancers of human bladder: relation to clinicopathological and molecular parameters
    Kalogris, Cristina
    Caprodossi, Sara
    Amantini, Consuelo
    Lambertucci, Federica
    Nabissi, Massimo
    Morelli, Maria Beatrice
    Farfariello, Valerio
    Filosa, Alessandra
    Emiliozzi, Maria Cristina
    Mammana, Gabriele
    Santoni, Giorgio
    HISTOPATHOLOGY, 2010, 57 (05) : 744 - 752
  • [39] Opposing Roles for Cannabinoid Receptor Type-1 (CB1) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats
    Plínio C Casarotto
    Ana Luisa B Terzian
    Daniele C Aguiar
    Hélio Zangrossi
    Francisco S Guimarães
    Carsten T Wotjak
    Fabrício A Moreira
    Neuropsychopharmacology, 2012, 37 : 478 - 486
  • [40] Chronic pain models amplify transient receptor potential vanilloid 1 (TRPV1) receptor responses in adult rat spinal dorsal horn
    Uta, Daisuke
    Yoshimura, Megumu
    Koga, Kohei
    NEUROPHARMACOLOGY, 2019, 160